ABVX (Abivax) Interest Expense : $-15.06 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Abivax Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Abivax's interest expense for the six months ended in Dec. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-15.06 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Abivax's Operating Income for the six months ended in Dec. 2024 was $ 0.00 Mil. Abivax's Interest Expense for the six months ended in Dec. 2024 was $ 0.00 Mil. GuruFocus does not calculate Abivax's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abivax Interest Expense Historical Data

The historical data trend for Abivax's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abivax Interest Expense Chart

Abivax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-2.51

-4.02

-7.35

-15.08

-13.02

Abivax Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Dec24
Interest Expense	Get a 7-Day Free Trial															-9.86	2.53	-2.52	-12.54	-

Abivax Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-15.06 Mil.

Abivax (NAS:ABVX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abivax's Interest Expense for the six months ended in Dec. 2024 was $0.00 Mil. Its Operating Income for the six months ended in Dec. 2024 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was $56.12 Mil.

Abivax's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

GuruFocus does not calculate Abivax's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Abivax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abivax SA (NAS:ABVX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

AAVXF:USA 0RA9:UK ABVX:France 2X1:Germany

Address

7-11 boulevard Haussmann, Paris, FRA, 75009

Website

https://www.abivax.com

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.